Neurocrine Biosciences
NBIX
NBIX
417 hedge funds and large institutions have $8.63B invested in Neurocrine Biosciences in 2020 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 188 increasing their positions, 109 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
23% less capital invested
Capital invested by funds: $11.1B → $8.63B (-$2.51B)
70% less call options, than puts
Call options by funds: $40.5M | Put options by funds: $136M
Holders
417
Holding in Top 10
7
Calls
$40.5M
Puts
$136M
Top Buyers
| 1 | +$73.8M | |
| 2 | +$63.9M | |
| 3 | +$54.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.4M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$27.5M |
Top Sellers
| 1 | -$175M | |
| 2 | -$66.5M | |
| 3 | -$57M | |
| 4 |
Jennison Associates
New York
|
-$41.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$37.8M |